Distinctive roles of L-type calcium channels subtypes within the dorsal hippocampus in formation of morphine withdrawal-induced aversion in rats
Although the negative effects coming along with opiate withdrawal are in part modulated by L-type calcium channels (LTCCs), the distinctive physiological properties and functions of LTCCs subtypes suggest differential roles of subtypes during withdrawal. The present study aimed to examine the contri...
Gespeichert in:
Veröffentlicht in: | Progress in neuro-psychopharmacology & biological psychiatry 2023-12, Vol.127, p.110818-110818, Article 110818 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 110818 |
---|---|
container_issue | |
container_start_page | 110818 |
container_title | Progress in neuro-psychopharmacology & biological psychiatry |
container_volume | 127 |
creator | Duan, Ying Jin, Lingtong Du, Wenjie Meng, Yiming Liang, Jing Zhang, Jianjun Sui, Nan Shen, Fang |
description | Although the negative effects coming along with opiate withdrawal are in part modulated by L-type calcium channels (LTCCs), the distinctive physiological properties and functions of LTCCs subtypes suggest differential roles of subtypes during withdrawal. The present study aimed to examine the contributions of LTCC subtypes, Cav1.2 and Cav1.3, within the dorsal hippocampus (DH) in naloxone-precipitated morphine withdrawal using the conditioned place aversion (CPA) paradigm. Firstly, we injected the non-specific LTCCs antagonist verapamil into the DH of morphine-dependent rats before conditioning an environment with naloxone-precipitated withdrawal. Our results showed that verapamil blocked the acquisition of CPA. Then, to explore the molecular mechanisms of LTCCs subtypes during withdrawal, we measured the protein expression of Cav1.2 and Cav1.3 in morphine-dependent rats under different conditions. In morphine-dependent rats, conditioning with withdrawal increased Cav1.2 expression in the membrane, while only acute naloxone injection increased the membrane expression of Cav1.3. To further determine the causal roles of LTCCs subtypes in the withdrawal process, we used Cav1.2 siRNA or Cav1.3 shRNA to knock down the expression of subtypes and detected the effects on CPA and somatic withdrawal signs in morphine-dependent rats. Cav1.2 siRNA, but not Cav1.3 shRNA, inhibited the acquirement of CPA and relieved somatic withdrawal symptoms. Together, our findings reveal that Cav1.2, but not Cav1.3 plays an important role in mediating morphine withdrawal, suggesting this subtype may serve as a potential therapeutic target for the treatment of negative effects in opiate dependence.
•The contributions of LTCC subtypes, Cav1.2 and Cav1.3, within the dorsal hippocampus (DH) in naloxone-precipitated morphine withdrawal using the conditioned place aversion paradigm.•In morphine-dependent rats, conditioning with withdrawal increased Cav1.2 expression in the membrane, while only acute naloxone injection increased the membrane expression of Cav1.3.•Cav1.2, but not Cav1.3 play an important role in mediating conditioned aversion induced by naloxone-precipitated morphine withdrawal. |
doi_str_mv | 10.1016/j.pnpbp.2023.110818 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2829426413</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0278584623001045</els_id><sourcerecordid>2829426413</sourcerecordid><originalsourceid>FETCH-LOGICAL-c359t-af138864a1d4cd73e492e816db83fc2d36ab0161f6b87ca35d9c13eee2296dea3</originalsourceid><addsrcrecordid>eNp9kcuO1DAQRS0EYpqBL0BCXrJJ40c67SxYoOExI7XEBtaWY1fUbiW2cTk9mr_gk3GmB5asqqQ6t0p1LyFvOdtyxrsPp20KaUhbwYTccs4UV8_Ihqu9alrBu-dkw0Ttd6rtrsgrxBNjjEsmX5IruZet6lq-Ib8_eyw-2OLPQHOcAGkc6aEpDwmoNZP1y0zt0YQAE1JchnWA9N6Xow-0HIG6mNFM9OhTitbMaUFaJ2PMsyk-hnXdHHOqODzKXDb3Zmp8cIsFR80ZMq5cFWVT8DV5MZoJ4c1TvSY_v375cXPbHL5_u7v5dGis3PWlMSOXqr5guGut20toewGKd25QcrTCyc4M1SQ-doPaWyN3rrdcAoAQfefAyGvy_rI35fhrASx69mhhmkyAuKAWSvStqB7JisoLanNEzDDqlP1s8oPmTK9R6JN-jEKvUehLFFX17unAMszg_mn-el-BjxegOgtnD1mj9RCqKT6DLdpF_98DfwC5J59l</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2829426413</pqid></control><display><type>article</type><title>Distinctive roles of L-type calcium channels subtypes within the dorsal hippocampus in formation of morphine withdrawal-induced aversion in rats</title><source>Elsevier ScienceDirect Journals Complete</source><creator>Duan, Ying ; Jin, Lingtong ; Du, Wenjie ; Meng, Yiming ; Liang, Jing ; Zhang, Jianjun ; Sui, Nan ; Shen, Fang</creator><creatorcontrib>Duan, Ying ; Jin, Lingtong ; Du, Wenjie ; Meng, Yiming ; Liang, Jing ; Zhang, Jianjun ; Sui, Nan ; Shen, Fang</creatorcontrib><description>Although the negative effects coming along with opiate withdrawal are in part modulated by L-type calcium channels (LTCCs), the distinctive physiological properties and functions of LTCCs subtypes suggest differential roles of subtypes during withdrawal. The present study aimed to examine the contributions of LTCC subtypes, Cav1.2 and Cav1.3, within the dorsal hippocampus (DH) in naloxone-precipitated morphine withdrawal using the conditioned place aversion (CPA) paradigm. Firstly, we injected the non-specific LTCCs antagonist verapamil into the DH of morphine-dependent rats before conditioning an environment with naloxone-precipitated withdrawal. Our results showed that verapamil blocked the acquisition of CPA. Then, to explore the molecular mechanisms of LTCCs subtypes during withdrawal, we measured the protein expression of Cav1.2 and Cav1.3 in morphine-dependent rats under different conditions. In morphine-dependent rats, conditioning with withdrawal increased Cav1.2 expression in the membrane, while only acute naloxone injection increased the membrane expression of Cav1.3. To further determine the causal roles of LTCCs subtypes in the withdrawal process, we used Cav1.2 siRNA or Cav1.3 shRNA to knock down the expression of subtypes and detected the effects on CPA and somatic withdrawal signs in morphine-dependent rats. Cav1.2 siRNA, but not Cav1.3 shRNA, inhibited the acquirement of CPA and relieved somatic withdrawal symptoms. Together, our findings reveal that Cav1.2, but not Cav1.3 plays an important role in mediating morphine withdrawal, suggesting this subtype may serve as a potential therapeutic target for the treatment of negative effects in opiate dependence.
•The contributions of LTCC subtypes, Cav1.2 and Cav1.3, within the dorsal hippocampus (DH) in naloxone-precipitated morphine withdrawal using the conditioned place aversion paradigm.•In morphine-dependent rats, conditioning with withdrawal increased Cav1.2 expression in the membrane, while only acute naloxone injection increased the membrane expression of Cav1.3.•Cav1.2, but not Cav1.3 play an important role in mediating conditioned aversion induced by naloxone-precipitated morphine withdrawal.</description><identifier>ISSN: 0278-5846</identifier><identifier>EISSN: 1878-4216</identifier><identifier>DOI: 10.1016/j.pnpbp.2023.110818</identifier><identifier>PMID: 37348641</identifier><language>eng</language><publisher>England: Elsevier Inc</publisher><subject>conditioned place aversion (CPA) ; dorsal hippocampus (DH) ; LTCCs subtypes ; Opiate withdrawal ; RNA interference</subject><ispartof>Progress in neuro-psychopharmacology & biological psychiatry, 2023-12, Vol.127, p.110818-110818, Article 110818</ispartof><rights>2023</rights><rights>Copyright © 2023. Published by Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c359t-af138864a1d4cd73e492e816db83fc2d36ab0161f6b87ca35d9c13eee2296dea3</citedby><cites>FETCH-LOGICAL-c359t-af138864a1d4cd73e492e816db83fc2d36ab0161f6b87ca35d9c13eee2296dea3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.pnpbp.2023.110818$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37348641$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Duan, Ying</creatorcontrib><creatorcontrib>Jin, Lingtong</creatorcontrib><creatorcontrib>Du, Wenjie</creatorcontrib><creatorcontrib>Meng, Yiming</creatorcontrib><creatorcontrib>Liang, Jing</creatorcontrib><creatorcontrib>Zhang, Jianjun</creatorcontrib><creatorcontrib>Sui, Nan</creatorcontrib><creatorcontrib>Shen, Fang</creatorcontrib><title>Distinctive roles of L-type calcium channels subtypes within the dorsal hippocampus in formation of morphine withdrawal-induced aversion in rats</title><title>Progress in neuro-psychopharmacology & biological psychiatry</title><addtitle>Prog Neuropsychopharmacol Biol Psychiatry</addtitle><description>Although the negative effects coming along with opiate withdrawal are in part modulated by L-type calcium channels (LTCCs), the distinctive physiological properties and functions of LTCCs subtypes suggest differential roles of subtypes during withdrawal. The present study aimed to examine the contributions of LTCC subtypes, Cav1.2 and Cav1.3, within the dorsal hippocampus (DH) in naloxone-precipitated morphine withdrawal using the conditioned place aversion (CPA) paradigm. Firstly, we injected the non-specific LTCCs antagonist verapamil into the DH of morphine-dependent rats before conditioning an environment with naloxone-precipitated withdrawal. Our results showed that verapamil blocked the acquisition of CPA. Then, to explore the molecular mechanisms of LTCCs subtypes during withdrawal, we measured the protein expression of Cav1.2 and Cav1.3 in morphine-dependent rats under different conditions. In morphine-dependent rats, conditioning with withdrawal increased Cav1.2 expression in the membrane, while only acute naloxone injection increased the membrane expression of Cav1.3. To further determine the causal roles of LTCCs subtypes in the withdrawal process, we used Cav1.2 siRNA or Cav1.3 shRNA to knock down the expression of subtypes and detected the effects on CPA and somatic withdrawal signs in morphine-dependent rats. Cav1.2 siRNA, but not Cav1.3 shRNA, inhibited the acquirement of CPA and relieved somatic withdrawal symptoms. Together, our findings reveal that Cav1.2, but not Cav1.3 plays an important role in mediating morphine withdrawal, suggesting this subtype may serve as a potential therapeutic target for the treatment of negative effects in opiate dependence.
•The contributions of LTCC subtypes, Cav1.2 and Cav1.3, within the dorsal hippocampus (DH) in naloxone-precipitated morphine withdrawal using the conditioned place aversion paradigm.•In morphine-dependent rats, conditioning with withdrawal increased Cav1.2 expression in the membrane, while only acute naloxone injection increased the membrane expression of Cav1.3.•Cav1.2, but not Cav1.3 play an important role in mediating conditioned aversion induced by naloxone-precipitated morphine withdrawal.</description><subject>conditioned place aversion (CPA)</subject><subject>dorsal hippocampus (DH)</subject><subject>LTCCs subtypes</subject><subject>Opiate withdrawal</subject><subject>RNA interference</subject><issn>0278-5846</issn><issn>1878-4216</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kcuO1DAQRS0EYpqBL0BCXrJJ40c67SxYoOExI7XEBtaWY1fUbiW2cTk9mr_gk3GmB5asqqQ6t0p1LyFvOdtyxrsPp20KaUhbwYTccs4UV8_Ihqu9alrBu-dkw0Ttd6rtrsgrxBNjjEsmX5IruZet6lq-Ib8_eyw-2OLPQHOcAGkc6aEpDwmoNZP1y0zt0YQAE1JchnWA9N6Xow-0HIG6mNFM9OhTitbMaUFaJ2PMsyk-hnXdHHOqODzKXDb3Zmp8cIsFR80ZMq5cFWVT8DV5MZoJ4c1TvSY_v375cXPbHL5_u7v5dGis3PWlMSOXqr5guGut20toewGKd25QcrTCyc4M1SQ-doPaWyN3rrdcAoAQfefAyGvy_rI35fhrASx69mhhmkyAuKAWSvStqB7JisoLanNEzDDqlP1s8oPmTK9R6JN-jEKvUehLFFX17unAMszg_mn-el-BjxegOgtnD1mj9RCqKT6DLdpF_98DfwC5J59l</recordid><startdate>20231220</startdate><enddate>20231220</enddate><creator>Duan, Ying</creator><creator>Jin, Lingtong</creator><creator>Du, Wenjie</creator><creator>Meng, Yiming</creator><creator>Liang, Jing</creator><creator>Zhang, Jianjun</creator><creator>Sui, Nan</creator><creator>Shen, Fang</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20231220</creationdate><title>Distinctive roles of L-type calcium channels subtypes within the dorsal hippocampus in formation of morphine withdrawal-induced aversion in rats</title><author>Duan, Ying ; Jin, Lingtong ; Du, Wenjie ; Meng, Yiming ; Liang, Jing ; Zhang, Jianjun ; Sui, Nan ; Shen, Fang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c359t-af138864a1d4cd73e492e816db83fc2d36ab0161f6b87ca35d9c13eee2296dea3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>conditioned place aversion (CPA)</topic><topic>dorsal hippocampus (DH)</topic><topic>LTCCs subtypes</topic><topic>Opiate withdrawal</topic><topic>RNA interference</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Duan, Ying</creatorcontrib><creatorcontrib>Jin, Lingtong</creatorcontrib><creatorcontrib>Du, Wenjie</creatorcontrib><creatorcontrib>Meng, Yiming</creatorcontrib><creatorcontrib>Liang, Jing</creatorcontrib><creatorcontrib>Zhang, Jianjun</creatorcontrib><creatorcontrib>Sui, Nan</creatorcontrib><creatorcontrib>Shen, Fang</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Progress in neuro-psychopharmacology & biological psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Duan, Ying</au><au>Jin, Lingtong</au><au>Du, Wenjie</au><au>Meng, Yiming</au><au>Liang, Jing</au><au>Zhang, Jianjun</au><au>Sui, Nan</au><au>Shen, Fang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Distinctive roles of L-type calcium channels subtypes within the dorsal hippocampus in formation of morphine withdrawal-induced aversion in rats</atitle><jtitle>Progress in neuro-psychopharmacology & biological psychiatry</jtitle><addtitle>Prog Neuropsychopharmacol Biol Psychiatry</addtitle><date>2023-12-20</date><risdate>2023</risdate><volume>127</volume><spage>110818</spage><epage>110818</epage><pages>110818-110818</pages><artnum>110818</artnum><issn>0278-5846</issn><eissn>1878-4216</eissn><abstract>Although the negative effects coming along with opiate withdrawal are in part modulated by L-type calcium channels (LTCCs), the distinctive physiological properties and functions of LTCCs subtypes suggest differential roles of subtypes during withdrawal. The present study aimed to examine the contributions of LTCC subtypes, Cav1.2 and Cav1.3, within the dorsal hippocampus (DH) in naloxone-precipitated morphine withdrawal using the conditioned place aversion (CPA) paradigm. Firstly, we injected the non-specific LTCCs antagonist verapamil into the DH of morphine-dependent rats before conditioning an environment with naloxone-precipitated withdrawal. Our results showed that verapamil blocked the acquisition of CPA. Then, to explore the molecular mechanisms of LTCCs subtypes during withdrawal, we measured the protein expression of Cav1.2 and Cav1.3 in morphine-dependent rats under different conditions. In morphine-dependent rats, conditioning with withdrawal increased Cav1.2 expression in the membrane, while only acute naloxone injection increased the membrane expression of Cav1.3. To further determine the causal roles of LTCCs subtypes in the withdrawal process, we used Cav1.2 siRNA or Cav1.3 shRNA to knock down the expression of subtypes and detected the effects on CPA and somatic withdrawal signs in morphine-dependent rats. Cav1.2 siRNA, but not Cav1.3 shRNA, inhibited the acquirement of CPA and relieved somatic withdrawal symptoms. Together, our findings reveal that Cav1.2, but not Cav1.3 plays an important role in mediating morphine withdrawal, suggesting this subtype may serve as a potential therapeutic target for the treatment of negative effects in opiate dependence.
•The contributions of LTCC subtypes, Cav1.2 and Cav1.3, within the dorsal hippocampus (DH) in naloxone-precipitated morphine withdrawal using the conditioned place aversion paradigm.•In morphine-dependent rats, conditioning with withdrawal increased Cav1.2 expression in the membrane, while only acute naloxone injection increased the membrane expression of Cav1.3.•Cav1.2, but not Cav1.3 play an important role in mediating conditioned aversion induced by naloxone-precipitated morphine withdrawal.</abstract><cop>England</cop><pub>Elsevier Inc</pub><pmid>37348641</pmid><doi>10.1016/j.pnpbp.2023.110818</doi><tpages>1</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0278-5846 |
ispartof | Progress in neuro-psychopharmacology & biological psychiatry, 2023-12, Vol.127, p.110818-110818, Article 110818 |
issn | 0278-5846 1878-4216 |
language | eng |
recordid | cdi_proquest_miscellaneous_2829426413 |
source | Elsevier ScienceDirect Journals Complete |
subjects | conditioned place aversion (CPA) dorsal hippocampus (DH) LTCCs subtypes Opiate withdrawal RNA interference |
title | Distinctive roles of L-type calcium channels subtypes within the dorsal hippocampus in formation of morphine withdrawal-induced aversion in rats |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T14%3A59%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Distinctive%20roles%20of%20L-type%20calcium%20channels%20subtypes%20within%20the%20dorsal%20hippocampus%20in%20formation%20of%20morphine%20withdrawal-induced%20aversion%20in%20rats&rft.jtitle=Progress%20in%20neuro-psychopharmacology%20&%20biological%20psychiatry&rft.au=Duan,%20Ying&rft.date=2023-12-20&rft.volume=127&rft.spage=110818&rft.epage=110818&rft.pages=110818-110818&rft.artnum=110818&rft.issn=0278-5846&rft.eissn=1878-4216&rft_id=info:doi/10.1016/j.pnpbp.2023.110818&rft_dat=%3Cproquest_cross%3E2829426413%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2829426413&rft_id=info:pmid/37348641&rft_els_id=S0278584623001045&rfr_iscdi=true |